Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

NCT01776203 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Inadequate enrollment

Conditions

Dysfunctional Uterine Bleeding

Interventions

DRUG: Medroxyprogesterone 17-Acetate

Sponsor

Kaiser Permanente